The ReNEW study for dry AMD is evaluating the efficacy, safety, and pharmacokinetics of daily subcutaneous injections of ...
The findings of this model support KIO-104 as a promising therapeutic candidate for both the prevention and treatment of PVR.
The authors commented that the patient’s "age, relative acute onset, and lack of medical history make this an atypical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results